Log In
BCIQ
Print this Print this
 

Granulocyte macrophage colony-stimulating factor (GM-CSF) receptor (CSF2RA) (GMR) (CD116)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Granulocyte macrophage colony-stimulating factor (GM-CSF) receptor (CSF2RA) (GMR) (CD116)

BCIQ
Print ChartPrint this
Marketed, 1 Phase III, 1 Phase II, 1 Phase II, 1 Phase II, 2 Phase I, 1 Phase I, 1 IND, 1
Phase of DevelopmentINDPhase IPhase IIPhase IIIMarketed
Autoimmune

-

1

2

-

-

Cancer

1

1

1

-

1

Hematology

-

-

-

1

-

Inflammation

-

-

1

-

-




 Products Targeting Granulocyte macrophage colony-stimulating factor (GM-CSF) receptor (CSF2RA) (GMR) (CD116)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

4

$2,949.9M

$102.5M

$12.6M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today